SCHEMBL7475272

SCHEMBL7475272

c1ccc(Cn2cccc2)nc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
PKM P14618 1/20 0.52
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
HRH1 P35367 1/20 0.47
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LIN28A Q9H9Z2 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
LMNA P02545 1/20 0.45
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
KDM4C Q9H3R0 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRA5 P31644 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30880299 1.00 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1PKMCYP1A2
SCHEMBL9594114 0.84 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1PKMCYP1A2
SCHEMBL12841354 0.81 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1PKMCYP1A2
SCHEMBL2716739 0.80 CYP11B1 (0.59) CYP1A2MAPT
SCHEMBL31408151 0.80 CYP11B1 (0.59) CYP1A2MAPT
SCHEMBL27494735 0.79 HSD17B10 (0.54) ALDH1A1CYP1A2HRH1LMNAHRH3
SCHEMBL19260079 0.78 MAPT (0.47) ALDH1A1KMT2AMEN1PKMCYP1A2
SCHEMBL15499470 0.75 PON1 (0.51) ALDH1A1KMT2AMEN1PKMCYP1A2
SCHEMBL17457945 0.75 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1PKMCYP1A2
SCHEMBL1333260 0.74 CYP1A2 (0.71) ALDH1A1KMT2ACYP1A2CYP2C19HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101678011-A Spiro-indolinone compounds MERCK & CO INC 2010-03-24 CN claimed
CN-115057894-B Environment-friendly drier, and preparation method and application thereof 上海佰奥聚新材料科技有限公司 2024-04-05 CN disclosed
CN-117820255-A Application of catalyst and degradation method of ester substance 上海科技大学 2024-04-05 CN disclosed
CN-115057894-A Environment-friendly drier, preparation method and application 上海佰奥聚新材料科技有限公司 2022-09-16 CN disclosed
CN-104903320-B Nitrogen-containing heterocycle compound or its salt 富士胶片株式会社 2018-11-13 CN disclosed
CN-107011341-A 1H-pyrrolo [2,3-b ] pyridine derivatives and their use as kinase inhibitors 沃纳利斯(R&D)有限公司 2017-08-04 CN disclosed
CN-106866658-A 1H-pyrrolo [2,3-b ] pyridine derivatives and their use as kinase inhibitors 沃纳利斯(R&D)有限公司 2017-06-20 CN disclosed
US-20130096334-A1 Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst The United States of America as represented by the Administrator of the United States Environment Pr (US) 2013-04-18 US disclosed
US-20130096334-A1 Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst The United States of America as represented by the Administrator of the United States Environment Pr (US) 2013-04-18 US disclosed
US-8324125-B2 Magnetic nanoparticle-supported glutathione as a sustainable organocatalyst THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY (US) 2012-12-04 US disclosed
US-20110054180-A1 Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst USA as Represented by the Administrator of U.S. Environmental Protection Agency (US) 2011-03-03 US disclosed
US-20110054180-A1 Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst USA as Represented by the Administrator of U.S. Environmental Protection Agency (US) 2011-03-03 US disclosed
CN-101678011-A Spiro-indolinone compounds MERCK & CO INC 2010-03-24 CN disclosed
EP-1246799-A1 SUBSTITUTED PYRROLE MANNICH BASES TO COMBAT PAIN AND ALLERGIC REACTIONS Grünenthal GmbH (DE) 2002-10-09 EP disclosed
WO-2001047878-A1 SUBSTITUTED PYRROLE MANNICH BASES TO COMBAT PAIN AND ALLERGIC REACTIONS Grünenthal GmbH (DE) 2001-07-05 WO disclosed
WO-2001047882-A2 SUBSTANCE LIBRARY WHICH CAN BE OBTAINED BY REACTING ALDEHYDES WITH SECONDARY AMINES, ACID CHLORIDES AND NAPHTHOL, PYRROLE AND/OR INDOLE COMPOUNDS Grünenthal GmbH (DE) 2001-07-05 WO disclosed
US-4511575-A Antidiabetic pyrrolecarboxylic acids PFIZER INC. (US) 1985-04-16 US disclosed
US-4511576-A Antidiabetic pyrrolecarboxylic acids PFIZER INC. (US) 1985-04-16 US disclosed
US-4351843-A LOWERING BLOOD GLUCOSE PFIZER INC. (US) 1982-09-28 US disclosed
US-4282242-A HYPOGLYCEMIC AGENTS PFIZER INC. (US) 1981-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054180-A1 Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst GSTK1, GSTA1, GSTP1 ALDH1A1 281/4885KMT2A 932/4885MEN1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.